Select your country

19.12.2017
STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and Nidda Healthcare GmbH
STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and Nidda Healthcare GmbH

STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and …

Read more

15.11.2017
STADA Health Report 2017: Young adults lack health education
STADA Health Report 2017: Young adults lack health education

STADA Health Report 2017: Young adults lack health education

Read more

09.11.2017
STADA shows good business development in the third quarter of 2017 and the first nine months
STADA shows good business development in the third quarter of 2017 and the first nine months

STADA shows good business development in the third quarter of 2017 and the first nine months

Read more

27.10.2017
Luc Slegers to hand over responsibility for STADA Europe after 26 years
Luc Slegers to hand over responsibility for STADA Europe after 26 years

Luc Slegers to hand over responsibility for STADA Europe after 26 years

Read more

17.10.2017
Frank Staud assumes overall responsibility for the STADA brand and communications
Frank Staud assumes overall responsibility for the STADA brand and communications

Frank Staud assumes overall responsibility for the STADA brand and communications

Read more

28.09.2017
Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of STADA Arzneimittel AG
Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of STADA Arzneimittel AG

Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of STADA Arzneimittel AG

Read more

27.09.2017
Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman
Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Read more

30.08.2017
STADA Annual General Meeting: Approval of the actions of the Executive Board for financial year 2016 postponed – guidance 2017 confirmed
STADA Annual General Meeting: Approval of the actions of the Executive Board for financial year 2016 postponed – guidance 2017 confirmed

STADA Annual General Meeting: Approval of the actions of the Executive Board for financial year 2016 postponed – guidance 2017 confirmed

Read more

25.08.2017
Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts
Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts

Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts

Read more

25.08.2017
Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven
Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven

Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven

Read more

25.08.2017
Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts
Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts

Following the successful takeover vote for STADA: Members of the Supervisory Board to step down from their posts

Read more

24.08.2017
Entering into negotiations of a domination and profit and loss pooling agreement between STADA Arzneimittel AG and Nidda Healthcare Holding AG
Entering into negotiations of a domination and profit and loss pooling agreement between STADA Arzneimittel AG and Nidda Healthcare Holding AG

Entering into negotiations of a domination and profit and loss pooling agreement between STADA Arzneimittel AG and Nidda Healthcare Holding …

Read more